Sopharma AD Capital Reinvestment Ratio
Sopharma AD capital reinvestment ratio. Sopharma AD (SPH) has a Capital Reinvestment Ratio of 1.72x as of December 2024, meaning it reinvests 2% of its operating cash flow (zł54.42 Million) in capital expenditures (zł93.50 Million). See Sopharma AD (SPH) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Sopharma AD (2011–2024)
Capital reinvestment ratio of Sopharma AD from 2011 to 2024. This chart tracks Sopharma AD's Capital Reinvestment Ratio across 11 annual periods. See how financially flexible is Sopharma AD to measure the company's free cash flow as a share of total liabilities.
Sopharma AD Capital Reinvestment Ratio by Year (2011–2024)
Sopharma AD capital reinvestment ratio by year from 2011 to 2024. For the full cash flow conversion analysis, see Sopharma AD cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (PLN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.58x | zł76.73 Million | zł121.39 Million | ▲ +64.6% |
| 2023 | 0.96x | zł45.03 Million | zł43.29 Million | ▲ +415.9% |
| 2022 | 0.19x | zł124.62 Million | zł23.22 Million | ▼ -81.0% |
| 2018 | 0.98x | zł28.34 Million | zł27.84 Million | ▲ +74.4% |
| 2017 | 0.56x | zł40.00 Million | zł22.53 Million | ▲ +56.5% |
| 2016 | 0.36x | zł50.64 Million | zł18.23 Million | ▼ -66.0% |
| 2015 | 1.06x | zł21.31 Million | zł22.59 Million | ▼ -18.0% |
| 2014 | 1.29x | zł20.18 Million | zł26.07 Million | ▲ +2.3% |
| 2013 | 1.26x | zł29.25 Million | zł36.96 Million | ▼ -29.9% |
| 2012 | 1.80x | zł35.20 Million | zł63.43 Million | ▲ +69.0% |
| 2011 | 1.07x | zł38.40 Million | zł40.97 Million | — |